Nasopharyngeal Carcinoma (NPC)
Bmi-1
plays an important role in the development
and progression of nasopharyngeal carcinoma, and that Bmi-1 is a
valuable marker for assessing the prognosis of nasopharyngeal
carcinoma patients.
PMID: 16778197
CENP-H protein
a valuable marker of NPC progression. High
CENP-H expression is associated with poor overall survival in
NPC patients.
PMID: 17255272
CYFRA 21-1
a new tumor marker in nasopharyngeal carcinoma.
PMID: 9604997
Cytokeratin 19 (CK-19
the presence of
CK-19 mRNA in the peripheral blood may be a potential marker of
micrometastasis for nasopharyngeal carcinoma (NPC).
PMID: 11802221
EBERs
can be used as a sensitive marker to identify nasopharyngeal carcinoma (NPC) cells at various metastatic sites by techniques of in situ hybridization, and that demonstration of EBERs in lesions of undifferentiated histology may be useful as a diagnostic adjunct for NPC presenting as metastatic cancer of unknown origin. PMID: 8646721
EBV DNA
Circulating EBV DNA as a tumor marker for nasopharyngeal carcinoma.
PMID: 12450734
EBV-specific DNase
may be a useful marker for detection of
patients with NPC, and they imply that individuals having high
levels of antibody to EBV DNase activity may have an increased
risk of development of NPC.
PMID: 2542436
Epstein-Barr virus-specific DNase is a marker for the early
detection of nasopharyngeal carcinoma.
PMID: 2995572
IgA/VCA
is of marginal significance in the monitoring
of nasopharyngeal
carcinoma (NPC) patients during
follow-up.
PMID: 7926060
MB-1
may be useful as a tumor marker of
nasopharyngeal
carcinoma (NPC).
PMID: 7510513
TK (thymidine kinase)
the TK ELISA presents a strong predictor of
NPC and, in its refined form, has improved pickup rates.
PMID: 11267982
TPS (Tissue
polypeptide specific antigen)
may have a
potential clinical role as a valuable tumor marker for
nasopharyngeal carcinoma (NPC).
PMID: 11205197
serum/plasma EBV
DNA constitutes a reliable tumor marker prior to, during, and after
treatment of NPC.
PMID: 10741733
VCA IgA
specific VCA IgA antibody may serve as a
better marker for screening nasopharyngeal carcinoma (NPC) than
EBV DNA detected by PCR.
PMID: 11316043